Literature DB >> 15819873

Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia.

C-I Kang1, S-H Kim, W B Park, K-D Lee, H-B Kim, E-C Kim, M-D Oh, K-W Choe.   

Abstract

Cases of community-acquired Pseudomonas aeruginosa bacteraemia (n = 39) that occurred at a tertiary-care hospital during a 5-year period were analysed retrospectively. The commonest underlying diseases were solid tumour (41%) and haematological malignancy (18%). Most (44%) of the patients were neutropenic, and 39% had septic shock at initial presentation. The 30-day attributable mortality rate was 39%. Two previously healthy patients were identified with fatal P. aeruginosa pneumonia with bacteraemia. P. aeruginosa bacteraemia is a fatal infection that should be considered in the differential diagnosis of patients presenting from the community with rapidly progressive sepsis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15819873     DOI: 10.1111/j.1469-0691.2005.01102.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  13 in total

1.  Is domestic tap water a risk for infections in neutropenic patients?

Authors:  H von Baum; M Bommer; A Forke; J Holz; P Frenz; N Wellinghausen
Journal:  Infection       Date:  2010-03-18       Impact factor: 3.553

2.  Pseudomonas aeruginosa Community-Onset Bloodstream Infections: Characterization, Diagnostic Predictors, and Predictive Score Development-Results from the PRO-BAC Cohort.

Authors:  Pedro María Martínez Pérez-Crespo; Álvaro Rojas; Joaquín Felipe Lanz-García; Pilar Retamar-Gentil; José María Reguera-Iglesias; Olalla Lima-Rodríguez; Alfonso Del Arco Jiménez; Jonathan Fernández Suárez; Alfredo Jover-Saenz; Josune Goikoetxea Aguirre; Eva León Jiménez; María Luisa Cantón-Bulnes; Pilar Ortega Lafont; Carlos Armiñanzas Castillo; Juan Sevilla Blanco; Jordi Cuquet Pedragosa; Lucía Boix-Palop; Berta Becerril Carral; Alberto Bahamonde-Carrasco; Teresa Marrodan Ciordia; Clara Natera Kindelán; Isabel María Reche Molina; Carmen Herrero Rodríguez; Inés Pérez Camacho; David Vinuesa García; Fátima Galán-Sánchez; Alejandro Smithson Amat; Esperanza Merino de Lucas; Antonio Sánchez-Porto; Marcos Guzmán García; Inmaculada López-Hernández; Jesús Rodríguez-Baño; Luis Eduardo López-Cortés
Journal:  Antibiotics (Basel)       Date:  2022-05-24

3.  Population-based study of the epidemiology and the risk factors for Pseudomonas aeruginosa bloodstream infection.

Authors:  M D Parkins; D B Gregson; J D D Pitout; T Ross; K B Laupland
Journal:  Infection       Date:  2009-12-12       Impact factor: 3.553

4.  Beneficial effect of probiotics on Pseudomonas aeruginosa-infected intestinal epithelial cells through inflammatory IL-8 and antimicrobial peptide human beta-defensin-2 modulation.

Authors:  Fu-Chen Huang; Yi-Ting Lu; Yu-Hsuan Liao
Journal:  Innate Immun       Date:  2020-09-28       Impact factor: 2.680

5.  Inappropriate initial antimicrobial therapy as a risk factor for mortality in patients with community-onset Pseudomonas aeruginosa bacteraemia.

Authors:  H S Cheong; C-I Kang; Y M Wi; K S Ko; D R Chung; N Y Lee; J-H Song; K R Peck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-25       Impact factor: 3.267

6.  Chitinase 3-Like 1 (Chil1) Regulates Survival and Macrophage-Mediated Interleukin-1β and Tumor Necrosis Factor Alpha during Pseudomonas aeruginosa Pneumonia.

Authors:  Chad R Marion; Jianmiao Wang; Lokesh Sharma; Ashley Losier; Wei Lui; Nathaniel Andrews; Jack A Elias; Barbara I Kazmierczak; Craig R Roy; Charles S Dela Cruz
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

7.  Impact of definitive therapy with beta-lactam monotherapy or combination with an aminoglycoside or a quinolone for Pseudomonas aeruginosa bacteremia.

Authors:  Ioannis A Bliziotis; Nicola Petrosillo; Argyris Michalopoulos; George Samonis; Matthew E Falagas
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

8.  Diversity of Antimicrobial Resistance and Virulence Determinants in Pseudomonas aeruginosa Associated with Fresh Vegetables.

Authors:  Kashina Allydice-Francis; Paul D Brown
Journal:  Int J Microbiol       Date:  2012-11-20

9.  Pseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase.

Authors:  Andrea Endimiani; Francesco Luzzaro; Beatrice Pini; Gianfranco Amicosante; Gian Maria Rossolini; Antonio Q Toniolo
Journal:  BMC Infect Dis       Date:  2006-03-16       Impact factor: 3.090

10.  Pseudomonas Aeruginosa Bacteraemia in Two UK District Hospitals.

Authors:  David A Enoch; Julie Kuzhively; Andrew Sismey; Alina Grynik; Johannis Andreas Karas
Journal:  Infect Dis Rep       Date:  2013-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.